You are here

Award Data

For best search results, use the search terms first and then apply the filters
Reset

The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.

Download all SBIR.gov award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.

  1. Geothermal Asset Integrity Model

    SBC: OLI SYSTEMS INC            Topic: C5321a

    C53-21a-271193Assuring trouble-free performance of downhole and surface components is critical for generation of low- cost electricity from geothermal energy systems. Because geothermal environments can be extremely corrosive, managing the corrosion of alloys used in geothermal system through a combination of proper alloy selection and operational practices is essential. Unfortunately, materials s ...

    SBIR Phase II 2023 Department of Energy
  2. SBIR Phase II:Development of a bioabsorbable tissue adhesive

    SBC: BEZWADA BIOMEDICAL LLC            Topic: BM

    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase II project is advancement in the development of an effective wound closure product for internal gastrointestinal (GI) surgical applications. Anastomotic leaks resulting from ineffective GI surgical wound closures are associated with significant healthcare and economic costs. Effective closure of wounds ...

    SBIR Phase II 2023 National Science Foundation
  3. SBIR Phase II:Formulation of a mRNA-Based Therapy for CTLN1 by Inverse Flash NanoPrecipitation

    SBC: Optimeos Life Sciences, Inc.            Topic: PT

    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase II project will be to enhance American and global healthcare through new technologies enabling clinical translation of gene therapies. One of the major unmet needs within biotechnology is a delivery technology that enables gene therapies to reach the desired organ within the body without raising an immu ...

    SBIR Phase II 2023 National Science Foundation
  4. SBIR Phase II: A machine learning-driven telerehabilitation solution designed to promote the personalized recovery of hand and arm functions post stroke

    SBC: Mee Eriksson            Topic: DH

    The broader impact/commercial potential of this Small Business Innovation Research (SBIR) Phase II project is to potentially improve the quality of life for individuals suffering arm and hand impairments from stroke, through a medical device for telerehabilitation. Each year, ~800,000 people have a stroke in the United States, and about 65% of them suffer long-term upper extremity impairments. Due ...

    SBIR Phase II 2023 National Science Foundation
  5. STTR Phase II:Scalable CO2 electrolyzers for the competitive carbon negative production of formic acid

    SBC: RENEWCO2 INC.            Topic: CT

    The broader impact of this Small Business Technology Transfer (STTR) Phase II project is the development of an electrocatalytic formic acid production process directly from carbon dioxide (CO2) and electricity. This process will mitigate greenhouse gas emissions while producing formic acid, currently used in agriculture for silage preservation, leather tanning, and the chemical industry. The econo ...

    STTR Phase II 2023 National Science Foundation
  6. Machine Learning Enhanced LIBS to Measure and Process Biofuels and Waste Coal for Gasifier Improved Operation

    SBC: Energy Research Company            Topic: C5421f

    The use of coal waste and biomass has significant environmental benefits, and it can contribute to promoting a low-carbon economy via hydrogen production. These feedstocks can be cost effective, are readily available, and in the case of biomass are renewable with the near elimination of greenhouse gases. But there are issues with gasifying waste coal and biomass. The first one is the widely varyin ...

    STTR Phase II 2023 Department of Energy
  7. Novel hand hygiene product to remove Clostridioides difficile spores

    SBC: Novaflux Inc.            Topic: NIAID

    7. Project Summary/AbstractC. difficile now causes more hospital-onset infections and deaths in the US than any other pathogen and is the most important cause of healthcare-associated diarrhea among adults in industrialized countries. In 2017, there were an estimated 462,100 combined healthcare- and community-associated C. difficile infection cases in the US, and 20,500 in-hospital deaths. In a ra ...

    SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health
  8. End to End, Cold Chain Validation Using Sample Attached History Log

    SBC: BIOTILLION LLC            Topic: OD

    Abstract Regenerative medicine therapies of various kinds are promising and rapidly growing, both in scale and type. The therapeutic products are not pills–they are living cells that are harvested from a patient (or sometimes a cell bank) and are shipped to a pharmaceutical company that modifies the cells and then sends them back to be re- injected into the patient. Logistics plays an outsize r ...

    SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health
  9. Development of the First-ever Safe and Effective Anterior Chamber Paracentesis Instrument to Treat and Diagnose Ocular Diseases

    SBC: F SQUARE MEDICAL LLC            Topic: 100

    PROJECT SUMMARY Despite advances in the treatment of ocular diseases, vision-threatening disease or eye injury remain the top 10 disabilities among adults. Several of these ocular conditions require an anterior chamber paracentesis (ACP). ACP is clinically indicated to reduce acutely elevated intraocular pressure (IOP) to avoid risk of permanent vision loss and to sample aqueous humor for disease ...

    SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health
  10. Developing and testing the Opioid Rapid Response System

    SBC: REAL PREVENTION LLC            Topic: NIDA

    Abstract This Phase II SBIR will develop and demonstrate the efficacy of the Opioid Rapid Response System (ORRS) to improve responses to opioid overdoses. Opioid overdoses exact a tremendous cost in lives and expenditures. Naloxone has been developed to counteract overdoses; however, the nature of these events requires a rapid response, a situation that challenges emergency responders in both ligh ...

    SBIR Phase II 2023 Department of Health and Human ServicesNational Institutes of Health
US Flag An Official Website of the United States Government